1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Klotz, Barbara ^a   Mentrup, Birgit ^a   Regensburger, Martina ^a   Zeck, Sabine ^a   Schneidereit, Jutta ^a   Schupp, Nicole ^a   Linden, Christian ^a   Merz, Cornelia ^a   Ebert, Regina ^a   Jakob, Franz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BETA GALACTOSIDASE; CALCITRIOL; ENDOGLIN; PROTEIN P16; THY 1 ANTIGEN; VITAMIN D RECEPTOR; BIOLOGICAL MARKER; CALCITRIOL RECEPTOR; DIHYDROXY VITAMIN D3; DIHYDROXY-VITAMIN D3; DRUG DERIVATIVE; REACTIVE OXYGEN METABOLITE; VITAMIN D;

ADIPOGENESIS; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL AGING; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CHONDROGENESIS; CLONOGENESIS; CONTROLLED STUDY; DRUG EFFECT; FIBROBLAST; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; P16 GENE; PROTEIN EXPRESSION; SENESCENCE; ANIMAL; CELL LINE; CLONOGENIC ASSAY; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; METABOLISM; MOUSE; TIME;

MUS;

ANIMALS; APOPTOSIS; BETA-GALACTOSIDASE; BIOLOGICAL MARKERS; CELL AGING; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL LINEAGE; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; MICE; MULTIPOTENT STEM CELLS; REACTIVE OXYGEN SPECIES; RECEPTORS, CALCITRIOL; TIME FACTORS; VITAMIN D;

EID: 84855387047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029959     Document Type: Article

References (44)

1. Christakos S, Dhawan P, Liu Y, Peng X, Porta A, (2003) New insights into the mechanisms of vitamin D action. J Cell Biochem 88: 695-705.
2. Holick MF, (2011) Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 12: 4-18.
3. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, et al. (1997) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16: 391-396.
4. van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA, (2001) Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr 11: 199-226.
5. Razzaque MS, Lanske B, (2006) Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol Med 12: 298-305.
6. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, et al. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444: 770-774.
7. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51.
8. Razzaque MS, Sitara D, Taguchi T, St-Arnaud R, Lanske B, (2006) Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 20: 720-722.
9. Sitara D, Razzaque MS, St-Arnaud R, Huang W, Taguchi T, et al. (2006) Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol 169: 2161-2170.
10. Ohnishi M, Nakatani T, Lanske B, Razzaque MS, (2009) Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 75: 1166-1172.
11. Hesse M, Frohlich LF, Zeitz U, Lanske B, Erben RG, (2007) Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol 26: 75-84.
12. Keisala T, Minasyan A, Lou YR, Zou J, Kalueff AV, et al. (2009) Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 115: 91-97.
13. Kirkwood TB, (2005) Understanding the odd science of aging. Cell 120: 437-447.
14. Cui H, Kong Y, Zhang H, (2012) Oxidative stress, mitochondrial dysfunction, and aging. J Signal Transduct 2012: 646354.
15. Johnson FB, Sinclair DA, Guarente L, (1999) Molecular biology of aging. Cell 96: 291-302.
16. Kohrle J, Jakob F, Contempre B, Dumont JE, (2005) Selenium, the thyroid, and the endocrine system. Endocr Rev 26: 944-984.
17. Abdallah BM, Kassem M, (2009) The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives. J Cell Physiol 218: 9-12.
18. Bianco P, Robey PG, (2001) Stem cells in tissue engineering. Nature 414: 118-121.
19. Christakos S, Dhawan P, Benn B, Porta A, Hediger M, et al. (2007) Vitamin D: molecular mechanism of action. Ann N Y Acad Sci 1116: 340-348.
20. Takahashi T, Nakamura K, Iho S, (1997) Differentiation of myeloid cells and 1,25-dihydroxyvitamin D3. Leuk Lymphoma 27: 25-33.
21. Chen S, Law CS, Gardner DG, (2010) Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity. J Steroid Biochem Mol Biol 118: 135-141.
22. Johnson CS, Hershberger PA, Bernardi RJ, McGuire TF, Trump DL, (2002) Vitamin D receptor: a potential target for intervention. Urology 60: 123-130; discussion 130-121.
23. Gonzalez-Pardo V, Martin D, Gutkind JS, Verstuyf A, Bouillon R, et al. (2010) 1alpha,25-dihydroxyvitamin D3 and its TX527 analog inhibit the growth of endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein-coupled receptor in vitro and in vivo. Endocrinology 151: 23-31.
24. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367.
25. Dreier R, Gunther BK, Mainz T, Nemere I, Bruckner P, (2008) Terminal differentiation of chick embryo chondrocytes requires shedding of a cell surface protein that binds 1,25-dihydroxyvitamin D3. J Biol Chem 283: 1104-1112.
26. Li J, (2011) Quiescence regulators for hematopoietic stem cell. Exp Hematol 39: 511-520.
27. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, et al. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015.
28. Furukawa-Hibi Y, Yoshida-Araki K, Ohta T, Ikeda K, Motoyama N, (2002) FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J Biol Chem 277: 26729-26732.
29. Pierantozzi E, Gava B, Manini I, Roviello F, Marotta G, et al. (2011) Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2. Stem Cells Dev 20: 915-923.
30. Jeong M, Piao ZH, Kim MS, Lee SH, Yun S, et al. (2009) Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions. J Immunol 183: 2495-2505.
31. Liu Y, Elf SE, Miyata Y, Sashida G, Huang G, et al. (2009) p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4: 37-48.
32. Spugnini EP, Campioni M, D'Avino A, Caruso G, Citro G, et al. (2007) Cell-cycle molecules in mesothelioma: an overview. J Exp Clin Cancer Res 26: 443-449.
33. Endoh M, Kobayashi Y, Yamakami Y, Yonekura R, Fujii M, et al. (2009) Coordinate expression of the human pregnancy-specific glycoprotein gene family during induced and replicative senescence. Biogerontology 10: 213-221.
34. Byers SW, Rowlands T, Beildeck M, Bong YS, (2011) Mechanism of action of vitamin D and the vitamin D receptor in colorectal cancer prevention and treatment. Rev Endocr Metab Disord.
35. Noth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, et al. (2002) Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20: 1060-1069.
36. Ebert R, Ulmer M, Zeck S, Meissner-Weigl J, Schneider D, et al. (2006) Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro. Stem Cells 24: 1226-1235.
37. Schutze N, Noth U, Schneidereit J, Hendrich C, Jakob F, (2005) Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation. Cell Commun Signal 3: 5.
38. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC, (1998) Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci U S A 95: 10614-10619.
39. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K, (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
40. LeBel CP, Ischiropoulos H, Bondy SC, (1992) Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5: 227-231.
41. Royall JA, Ischiropoulos H, (1993) Evaluation of 2′,7′-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys 302: 348-355.
42. Schupp N, Schmid U, Rutkowski P, Lakner U, Kanase N, et al. (2007) Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging. Am J Physiol Renal Physiol 292: F1427-1434.
43. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
44. Schilling T, Noth U, Klein-Hitpass L, Jakob F, Schutze N, (2007) Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells. Mol Cell Endocrinol 271: 1-17.